3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
申请人:Cerebrus Pharmaceuticals Limited
公开号:EP1006108A1
公开(公告)日:2000-06-07
A compound of the formula (1):
wherein A is
wherein R1, R2 and R3 are independently selected from H and alkyl;
wherein X is O, S, NR4 or a direct bond, wherein R4 is H or alkyl;
wherein Z is a saturated hydrocarbyl chain comprising from 1 to 20 carbon atoms interrupted by one or more heteroatom(s) and optionally substituted by one or more oxo substituent(s);
wherein q is 1, 2 or 3;
wherein if q is 2 or 3, then each A can be the same or different;
wherein the or each R5 is independently selected from H and alkyl;
wherein the or each R6 is independently selected from alkyl;
wherein n is 1 to 5;
wherein p is 0 to 4; and
wherein the sum of n and p is less than 6,
or a pharmaceutically acceptable salt thereof, and the use thereof in therapy, particularly for the treatment of a condition associated with oxidative stress, such as oxidative damage of the central nervous system or an acute or chronic neurological disorder such as traumatic brain injury, spinal cord injury, cerebral tumour, subharrachnoid haemorrage/cerebral vasospasm, cerebral ischaemia, stroke (ischaemic or haemorragic), Alzheimer's disease, Huntington's Disease, Parkinson's Disease, Friedrich's ataxia, motor neuron disease or multiple sclerosis.
其中A为其中R1、R2和R3分别独立选择自H和烷基;其中X为O、S、NR4或直接键,其中R4为H或烷基;其中Z为由1至20个碳原子组成的饱和碳氢链,中断一个或多个杂原子,并且可选择地被一个或多个氧代取代基取代;其中q为1、2或3;如果q为2或3,则每个A可以相同也可以不同;其中每个R5独立选择自H和烷基;其中每个R6独立选择自烷基;其中n为1至5;其中p为0至4;且n和p的总和小于6,或其药学上可接受的盐,以及其在治疗中的用途,特别用于治疗与氧化应激有关的疾病,如中枢神经系统的氧化损伤或急性或慢性神经系统疾病,如创伤性脑损伤、脊髓损伤、脑肿瘤、蛛网膜下腔出血/脑血管痉挛、脑缺血、中风(缺血性或出血性)、阿尔茨海默病、亨廷顿病、帕金森病、弗里德里希共济失调、运动神经元疾病或多发性硬化症。